Upgrade Now

Director/PDMR Shareholding

By Sharecast

Date: Monday 22 Dec 2025







RNS Number : 3697M
AstraZeneca PLC
22 December 2025
 



22 December 2025


 


Transaction by Person Discharging Managerial Responsibilities


 


AstraZeneca PLC (the Company) announces that, on 18 December 2025, it was notified of a transaction in the Company's ordinary shares of $0.25 each (Ordinary Shares), by Nazneen Rahman, Non-Executive Director, on 18 December 2025, as set out below.


 


 




















PDMR 



Position 



Nature of the transaction 



Quantity 



Price per Ordinary Share



Nazneen Rahman



Non-Executive Director



Sale of Ordinary Shares 



297



£134.96



 


 


Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018.


 


 













































































1


 



Details of the person discharging managerial responsibilities / person closely associated



a)


 



Name



Nazneen Rahman



2


 



Reason for the notification


 



a)


 



Position/status


 



Non-Executive Director



b)


 



Initial notification/Amendment



Initial notification



3


 



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



a)


 



Name



AstraZeneca PLC



b)


 



LEI



PY6ZZQWO2IZFZC3IOL08



4i


 



Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted



a)


 



Description of the financial instrument, type of instrument


 


Identification code



Ordinary Shares of US$0.25 each in AstraZeneca PLC


 


GB0009895292


 



b)


 



Nature of the transaction


 


 



Sale of Ordinary Shares of US$0.25 each in AstraZeneca PLC


 



c)


 



Price(s) and volume(s)


 



 














Price(s)



Volume(s)



£134.96



297





d)


 



Aggregated information


 


- Aggregated volume


- Price



Not applicable - single transaction


 


 


 


 



e)


 



Date of the transaction


 



18 December 2025



f)


 



Place of the transaction


 



LON



 


 


AstraZeneca


AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit www.astrazeneca.com and follow the Company on social media @AstraZeneca.


Contacts


For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.


 


Matthew Bowden


Company Secretary

AstraZeneca PLC


 






This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUKRURVUUUAUA

« Go back to news channel

..

Email this article to a friend

or share it with one of these popular networks:


Top of Page